Kaempferol Market to Reach US$7.1 billion by 2027 : IndustryARC
Growing awareness of health & wellness may drive the Kaempferol Market
HYDERABAD, TELANGANA, INDIA, December 9, 2022 /EINPresswire.com/ -- IndustryARC, in its latest report, predicts that Global Kaempferol Market size is forecast to reach US$7.1 billion by 2027, after growing at a CAGR of 3.8% during 2022-2027. kaempferol is a transparent material, easily soluble in water with ethanol, ethers, and others. kaempferol is a natural flavonol found in plant-derived products which act as an antioxidant to reduce stress and enhance oxygen levels in the body. Kaempferol helps to reduce the chances of cancers and is widely used for treatment. According to the American Cancer Society, around 1.9 million new cancer cases were diagnosed, and 608,570 cancer deaths occurred in the United States in 2021. Kaempferol is used in the food & beverages sector as a food additive and textile dyeing. The report offers a complete analysis of the market, its major segments, growth factors, trends, drivers and challengers, key players and more.
Click here to browse the complete report summary:
https://www.industryarc.com/Research/Global-Kaempferol-Industry-Market-Research-511621
Key takeaways:
This IndustryARC report on the Kaempferol Market highlights the following areas -
1. The Asia Pacific is expected to register a CAGR of 4.6% during the forecast period (2022-2027). The increasing demand for food & beverages and pharmaceutical products, among Asian countries such as China, India, Japan, and South Korea is driving the market for kaempferol.
2. Growing demand for kaempferol for the medication of cancer is expected to boost the demand for kaempferol during the forecast period.
3. Robust demand for natural flavonol kaempferol in functional food, food additives, and dietary supplements will help to increase the demand for kaempferol globally.
Interested in knowing more relevant information? Click here:
https://www.industryarc.com/pdfdownload.php?id=511621
Segmental Analysis :
1. The pharma grade segments accounted for around 42% of the market share in 2021 and are estimated to grow at a significant CAGR during the forecast period. The pharma grade kaempferol helps in the formulation of peel & capsules to treat a patient suffering from ovarian cancers.
2. Asia Pacific region held the largest share in the global kaempferol market in 2021 up to 39%, owing to the growing demand for dietary supplements, food additives, and functional food in developing countries like China, India, Indonesia, and others. Robust growth towards sports activities is one of the major factors increasing dietary supplement consumption in the region.
3. The pharma grade segments accounted for around 42% of the market share in 2021 and are estimated to grow at a significant CAGR during the forecast period. The pharma grade kaempferol helps in the formulation of peel & capsules to treat a patient suffering from ovarian cancers.
Competitive Landscape:
The top 5 players in the Kaempferol Industry are -
1. Aktin Chemicals
2. Foodchem
3. Risun Bio-Tech
4. TCI Chemical
5. Shaanxi NHK Technology
Click on the following link to buy the Kaempferol Market Report:
https://www.industryarc.com/reports/request-quote?id=511621
Why Choose IndustryARC?
IndustryARC is one of the leading market research and consulting firms in the world. It produces over 500 unique market reports annually. If you are looking for a detailed overview of a particular market, you can simply connect with the team at IndustryARC. You can not only buy your preferred market report from the website, but also get personalized assistance on specific reports.
Related Reports:
A. Ampicillin Market
https://www.industryarc.com/Report/15287/ampicillin-market.html
B. Acetohydroxamic Acid Market
https://www.industryarc.com/Report/15320/acetohydroxamic-acid-market.html
Contact Us:
Mr. Venkat Reddy
IndustryARC
Email: venkat@industryarc.com, sales@industryarc.com
USA: (+1) 970-236-3677, (+1) 815-656-4596
IND: (+91) 40-485-49062
Venkat Reddy
IndustryARC
+1 614-588-8538
venkat@industryarc.com
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
